Baclofen and the risk of fall and fracture in older adults: a real-world cohort study - Hwang YJ, Chang AR, Brotman DJ, Inker LA, Grams ME, Shin JI.
BACKGROUND: The growth of oral muscle relaxant prescriptions among older adults in the United States is concerning due to the drugs' adverse sedative effects. Baclofen is a gamma-aminobutyric acid agonist muscle relaxant that is associated with encephalopa... (Source: SafetyLit)
Source: SafetyLit - November 9, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Psychosis related to baclofen withdrawal or overdose: a systematic review - Phu PJJ, Looi JCL, Nair PC, Allison S, Chan SKW, Bastiampillai T.
OBJECTIVE: To systematically review case reports of psychosis related to withdrawal or overdose of baclofen, which is a gamma-aminobutyric acid (GABA) B agonist.
METHODS: PubMed, MEDLINE, CINAHL, and PsychINFO were searched to identify articles related t... (Source: SafetyLit)
Source: SafetyLit - July 6, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Baclofen Shows Limited Role in GERD Baclofen Shows Limited Role in GERD
The drug showed benefit in PPI refractory symptoms for patients with non-acid reflux.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - June 28, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Fleqsuvy (Baclofen Oral Suspension) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 16, 2022 Category: Drugs & Pharmacology Source Type: news
FDA Approves Fleqsuvy (baclofen oral suspension) for the Treatment of Spasticity
WOBURN, MA, February 7, 2022– Azurity Pharmaceuticals, Inc., a private specialty pharmaceutical company, focused on developing innovative products to meet the unique needs of patients with underserved conditions, today announced the U.S. Food... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 7, 2022 Category: Drugs & Pharmacology Source Type: news
Lyvispah (Baclofen Oral Granules) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 9, 2021 Category: Drugs & Pharmacology Source Type: news
FDA Approves Lyvispah (baclofen) Oral Granules for the Treatment of Spasticity
ROSWELL, Ga. and DUBLIN and HAMILTON, Bermuda, Dec. 7, 2021 /PRNewswire/ -- Saol Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has approved Saol ' s Lyvispah (baclofen) oral granules.
Lyvispah (lye-vis ' -pah) is... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 7, 2021 Category: Drugs & Pharmacology Source Type: news
Hudson Woman Sentenced to 15 Months for Tampering with Consumer Products and Unlawfully Obtaining Controlled Substances
FDA OCI, Kristina Coleman, Hudson NH, sentence, tampering, opioid, pharmacy technician, Nashua, oxycodone, baclofen, suboxone, muscle relaxant, replacement, controlled substance, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - March 2, 2021 Category: Medical Law Authors: DOJ Source Type: news
High-Dose Baclofen Curbs Agitation in Ventilation Patients With Unhealthy Alcohol Use High-Dose Baclofen Curbs Agitation in Ventilation Patients With Unhealthy Alcohol Use
Adults receiving mechanical ventilation who meet the criteria for unhealthy alcohol use have fewer agitation-related events when they ' re given high-dose baclofen, a new randomized trial finds.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - February 25, 2021 Category: Intensive Care Tags: Critical Care News Source Type: news
Association of baclofen with falls and fractures in patients with CKD - Muanda FT, Blake PG, Weir MA, Bathini L, Chauvin K, Dixon SN, McArthur E, Sontrop JM, Moist L, Kim RB, Garg AX.
Baclofen is a popular muscle relaxant that is eliminated primarily unchanged in the urine. We recently reported a higher risk of encephalopathy in a cohort of 15,942 older adults with chronic kidney disease (CKD) who started baclofen at ≥20 mg/day vs. ... (Source: SafetyLit)
Source: SafetyLit - February 15, 2021 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
Baclofen self-poisoning: is renal replacement therapy efficient in patient with normal kidney function? - Brunet M, L éger M, Billat PA, Lelièvre B, Lerolle N, Boels D, Le Roux G.
AIMS: We aimed at assessing the effectiveness of renal replacement therapy in patients severely self-poisoned with baclofen and with normal kidney function.
METHODS: A population pharmacokinetic model was built using analytical data extracted from 26 bac... (Source: SafetyLit)
Source: SafetyLit - October 22, 2020 Category: International Medicine & Public Health Tags: Poisoning Source Type: news
Hudson Woman Pleads Guilty to Tampering with Consumer Products and Unlawfully Obtaining Controlled Substances
FDA OCI, Kristina Coleman, Hudson NH, tampering, pharmacy technician, Nashua NH, prescription delivery, missing pills, oxycodone, opioids, different sizes, different imprints, baclofen, Suboxone, theft, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - October 21, 2020 Category: Medical Law Authors: DOJ Source Type: news
Coma and respiratory failure in a 2-year-old child after accidental overdose of Baclofen - Dasgupta K, Nielson S.
Baclofen (Lioresal) is a derivative of gamma-aminobutyric acid and is used in both adults and children mainly for symptomatic treatment of muscle spasticity. It is absorbed completely from the gastrointestinal tract, metabolized minimally in the liver and ... (Source: SafetyLit)
Source: SafetyLit - October 13, 2020 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news
Zydus Cadila gets USFDA nod to market muscle spasms tablets
The company has received final approval from the United States Food and Drug Administration (USFDA) to market Baclofen tablets in the strength of 5 mg, Zydus Cadila said in a statement. The product will be manufactured at the group's formulations manufacturing facility at Baddi, it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 17, 2020 Category: Pharmaceuticals Source Type: news
Baclofen: A Game Changer in Treatment of Alcohol Dependence Baclofen: A Game Changer in Treatment of Alcohol Dependence
While there are several drugs approved for the treatment of alcohol use disorder, very few patients with AUD are adequately treated. Baclofen looks to be a promising addition to the armamentarium.Alcohol and Alcoholism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 11, 2020 Category: Consumer Health News Tags: Psychiatry Journal Article Source Type: news